AbCellera Biologics Inc. financial data

Symbol
ABCL on Nasdaq
Industry
Pharmaceutical Preparations
Location
2215 Yukon Street, Vancouver, British Columbia, Canada
State of incorporation
British Columbia, Canada
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 6, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 835 % -8.34%
Debt-to-equity 28.4 % +11.8%
Return On Equity -13.4 % -121%
Return On Assets -10.4 % -116%
Operating Margin -815 % -917%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 295M shares +1.84%
Common Stock, Shares, Outstanding 291M shares +1.39%
Common Stock, Value, Issued 770M USD +3.39%
Weighted Average Number of Shares Outstanding, Basic 294M shares +1.84%
Weighted Average Number of Shares Outstanding, Diluted 294M shares +1.84%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 33.1M USD -77.2%
Research and Development Expense 167M USD +15.8%
Selling and Marketing Expense 13.1M USD -2.41%
General and Administrative Expense 67.9M USD +18.1%
Operating Income (Loss) -269M USD -132%
Nonoperating Income (Expense) 90.5M USD +99.6%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -179M USD -152%
Income Tax Expense (Benefit) -25.5M USD -970%
Net Income (Loss) Attributable to Parent -153M USD -107%
Earnings Per Share, Basic -0.53 USD/shares -104%
Earnings Per Share, Diluted -0.53 USD/shares -96.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 148M USD -17.5%
Cash, Cash Equivalents, and Short-term Investments 670M USD
Other Assets, Current 40.1M USD -37.8%
Assets, Current 772M USD -17.1%
Operating Lease, Right-of-Use Asset 70.2M USD
Intangible Assets, Net (Excluding Goodwill) 85.7M USD -32.4%
Goodwill 47.8M USD 0%
Other Assets, Noncurrent 113M USD -0.82%
Assets 1.41B USD -8.11%
Employee-related Liabilities, Current 4.36M USD +12.9%
Contract with Customer, Liability, Current 6.4M USD -25.1%
Liabilities, Current 70.4M USD -40.8%
Contract with Customer, Liability, Noncurrent 7.97M USD -71.2%
Deferred Income Tax Liabilities, Net 21.7M USD -34.5%
Operating Lease, Liability, Noncurrent 66.5M USD -14.9%
Other Liabilities, Noncurrent 6.35M USD +172%
Liabilities 302M USD -11.9%
Accumulated Other Comprehensive Income (Loss), Net of Tax -2.07M USD -9.16%
Retained Earnings (Accumulated Deficit) 202M USD -43.1%
Stockholders' Equity Attributable to Parent 1.11B USD -7.02%
Liabilities and Equity 1.41B USD -8.11%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -41.7M USD +5.35%
Net Cash Provided by (Used in) Financing Activities 2.83M USD
Net Cash Provided by (Used in) Investing Activities 29.9M USD
Common Stock, Shares, Issued 291M shares +1.39%
Common Stock, Par or Stated Value Per Share 0 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -9.75M USD +95%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 173M USD -15.4%
Deferred Tax Assets, Valuation Allowance 33.8M USD +152%
Deferred Tax Assets, Gross 81.2M USD +71.1%
Operating Lease, Liability 77.4M USD -5.93%
Depreciation 13.5M USD +21%
Payments to Acquire Property, Plant, and Equipment 24.1M USD +61.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -153M USD -101%
Operating Lease, Liability, Current 5.6M USD -5.88%
Lessee, Operating Lease, Liability, to be Paid, Year Two 9.69M USD +4.89%
Lessee, Operating Lease, Liability, to be Paid, Year One 9.81M USD +2.05%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Lessee, Operating Lease, Liability, to be Paid, Year Three 9.28M USD +1.62%
Deferred Tax Assets, Operating Loss Carryforwards 7.26M USD +43.6%
Lessee, Operating Lease, Liability, to be Paid, Year Four 8.25M USD -7.03%
Amortization of Intangible Assets 1.69M USD -36.4%
Share-based Payment Arrangement, Expense 67.5M USD +18.5%